AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,349 | +32.1% | 431 | +64.5% | 0.00% | – |
| Q2 2023 | $2,536 | -11.7% | 262 | 0.0% | 0.00% | – |
| Q1 2023 | $2,872 | +149.1% | 262 | -1.9% | 0.00% | – |
| Q4 2022 | $1,153 | -97.8% | 267 | -93.3% | 0.00% | -100.0% |
| Q2 2021 | $52,000 | +33.3% | 4,000 | +33.3% | 0.01% | +33.3% |
| Q1 2021 | $39,000 | -29.1% | 3,000 | -25.0% | 0.01% | -30.8% |
| Q4 2020 | $55,000 | +129.2% | 4,000 | +166.7% | 0.01% | +85.7% |
| Q2 2020 | $24,000 | -66.2% | 1,500 | -57.1% | 0.01% | -72.0% |
| Q4 2019 | $71,000 | +787.5% | 3,500 | +133.3% | 0.02% | +733.3% |
| Q3 2019 | $8,000 | -81.0% | 1,500 | -76.9% | 0.00% | -81.2% |
| Q2 2019 | $42,000 | +7.7% | 6,500 | +8.3% | 0.02% | 0.0% |
| Q1 2019 | $39,000 | +200.0% | 6,000 | +200.0% | 0.02% | +166.7% |
| Q4 2018 | $13,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |